Jump to main content

yr 〜
yr

Search results 2

Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study

Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study
Digital博士論文
小谷, 大輔2022-03-24
National Diet Library
  • Subject HeadingMetastatic colorectal cancer CAPOXIRI Triplet Bevacizumab FOLFOXIRI
  • Note (General)Background: FOLFOXIRI plus bevacizum......cizumab versus FOLFOXIRI plus bevacizumab, expecting a...

Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study

Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study
Digital博士論文
小谷, 大輔
Available onlineOther Libraries in Japan
  • Summary, etc.Background: FOLFOXIRI plus bevacizum......cizumab versus FOLFOXIRI plus bevacizumab, expecting a...
  • Subject HeadingMetastatic colorectal cancer CAPOXIRI Triplet Bevacizumab FOLFOXIRI

Reached to the end of result.

RSS